Lexpos News

/Lexpos News

DHSC to remove Transitional Payments from February

The Department of Health and Social Care (DHSC) has decided to reduce the Transitional Payment to zero from February 2023. PSNC’s Negotiating Team refused to accept this on the grounds that any reductions in payments at this point will be impossible for community pharmacy contractors to manage financially. We are also continuing to be clear [...]

The post DHSC to remove Transitional Payments from February appeared first on PSNC Website.

By |January 23rd, 2023|Lexpos News|Comments Off on DHSC to remove Transitional Payments from February

January 2023 Price Concessions 2nd Update

The Department of Health and Social Care (DHSC) has today (20/01/2023) granted the following list of price concessions for January 2023.   Drug Pack Size Price concession Carbocisteine 250mg/5ml oral solution 300 £8.50 Cinnarizine 15mg tablets 84 £7.51 Clarithromycin 500mg tablets 14 £10.48 Co-amoxiclav 250mg/125mg tablets 21 £3.54 Colecalciferol 1,000unit capsules 30 £8.40 Erythromycin 250mg [...]

The post January 2023 Price Concessions 2nd Update appeared first on PSNC Website.

By |January 20th, 2023|Lexpos News|Comments Off on January 2023 Price Concessions 2nd Update

PQS: More than 15,000 patients referred as part of NSAID audits

An evaluation of the 2018/19 and 2019/20 non-steroidal anti-inflammatory drugs (NSAID) Pharmacy Quality Scheme (PQS) audits has been published in the British Medical Journal Open Quality. The evaluation shows that community pharmacy teams spoke to over 165,000 patients during the two audit periods and referred more than 15,000 patients at risk of preventable harm from [...]

The post PQS: More than 15,000 patients referred as part of NSAID audits appeared first on PSNC Website.

By |January 19th, 2023|Lexpos News|Comments Off on PQS: More than 15,000 patients referred as part of NSAID audits

Class 3 Medicines Recall: Lacidipine 4 mg Film-Coated Tablets (Dr Reddy’s)

Class 3 Medicines recall: Lacidipine 4 mg Film-Coated Tablets (Dr Reddy’s Laboratories (UK) Ltd) Drug alert number: EL (23)A/03 Date issued: 19 January 2023 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 3 medicines recall for: Lacidipine 4 mg Film-Coated Tablets (Dr Reddy’s Laboratories (UK) Ltd), PL 08553/0503 Brief description of [...]

The post Class 3 Medicines Recall: Lacidipine 4 mg Film-Coated Tablets (Dr Reddy’s) appeared first on PSNC Website.

By |January 19th, 2023|Lexpos News|Comments Off on Class 3 Medicines Recall: Lacidipine 4 mg Film-Coated Tablets (Dr Reddy’s)

January 2023 Price Concessions 1st Update

The Department of Health and Social Care (DHSC) has today (19/01/2023) granted the following initial list of price concessions for January 2023. Drug Pack Size Price concession Amisulpride 100mg tablets 60 £20.29 Amisulpride 200mg tablets 60 £33.92 Amisulpride 50mg tablets 60 £13.09 Amoxicillin 125mg/5ml oral suspension sugar free 100 £3.70 Amoxicillin 250mg/5ml oral suspension 100 [...]

The post January 2023 Price Concessions 1st Update appeared first on PSNC Website.

By |January 19th, 2023|Lexpos News|Comments Off on January 2023 Price Concessions 1st Update